[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-363154-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-363154-en":131},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","the-role-of-gasdermin-b-mediated-pyroptosis-in-bladder-cancer-diagnosis","The Role of Gasdermin B-Mediated Pyroptosis in Bladder Cancer Diagnosis","","Bladder cancer is a prevalent malignancy of the urinary tract, and pyroptosis has attracted increasing interest as an inflammatory programmed cell death mechanism in cancer development. This study measured serum concentrations of gasdermin B (GSDM B) in bladder cancer patients and healthy controls, evaluating diagnostic performance versus CEA and CA19-9. Using ELISA for GSDM B and CMIA for CEA/CA19-9, results showed higher GSDM B in patients and positive correlations. ROC analysis indicated moderate, significant diagnostic value, with no significant differences by tumor grade, supporting GSDM B as a potential diagnostic marker in a multimarker panel.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/the-role-of-gasdermin-b-mediated-pyroptosis-in-bladder-cancer-diagnosis/363154/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/the-role-of-gasdermin-b-mediated-pyroptosis-in-bladder-cancer-diagnosis/363154.png","ImageObject",300,407,{"name":42,"@type":43},"Cart","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-17","2026-09-23",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",15,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What was the purpose of measuring GSDM B in this study?","Question",{"text":63,"@type":64},"The study aimed to assess serum GSDM B concentrations in bladder cancer patients and determine their potential diagnostic value compared with CEA and CA19-9.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How were GSDM B, CEA, and CA19-9 measured?",{"text":68,"@type":64},"GSDM B was measured by ELISA, while CEA and CA19-9 were measured by chemiluminescent microparticle immunoassay (CMIA).",{"name":70,"@type":61,"acceptedAnswer":71},"Does GSDM B performance depend on tumor grade in bladder cancer?",{"text":72,"@type":64},"No significant differences in GSDM B concentrations were observed between low- and high-grade tumors.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},363154,1790798657,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,120,123,127],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":117,"show_sort_weight":118,"slug":119},9,"Religion & Spirituality",20,"religion-spirituality",{"id":118,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":118,"slug":122},"World Cup","world-cup",{"id":124,"doc_module":4,"doc_module_name":25,"category_name":125,"show_sort_weight":124,"slug":126},10,"Lifestyle","lifestyle",{"id":128,"doc_module":4,"doc_module_name":25,"category_name":129,"show_sort_weight":97,"slug":130},19,"General","general",{"code":4,"msg":82,"data":132},{"doc_id":79,"user_id":133,"nickname":42,"user_avatar":134,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":140,"language":141,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":12,"update_tm":145,"read_time":146,"preview_page_count":33,"preview_urls":147},18829141979164,"https://eur-avatar.wpscdn.com/davatar_6f874abed73319feea01a86fa6f0fab8","Article  \nThe Role of Gasdermin B-Mediated Pyroptosis in Bladder Cancer Diagnosis  \nSara Pa˛czek 1, Michał Olkowicz 2, Jacek Kudelski 3 and Monika Gudowska-Sawczuk 4, *  \nAcademic Editor: Vija Lavinia  \nReceived: 25 March 2026  \nRevised: 11 April 2026  \nAccepted: 14 April 2026  \nPublished: 16 April 2026  \nCopyright: © 2026 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license.  \n1 Department of Biochemical Diagnostics, University Hospital of Bialystok, Waszyngtona 15A St., 15-269 Bialystok, Poland; [sara.paczek@uskwb.pl](sara.paczek@uskwb.pl)  \n2 Department of Urology, University Hospital of Bialystok, M. Skłodowskiej-Curie 24A St., 15-276 Bialystok, Poland; [m.olkowicz@yahoo.com](m.olkowicz@yahoo.com)  \n3 Department of Urology, Medical University of Bialystok, M. Skłodowskiej-Curie 24A St., 15-276 Bialystok, Poland; [jkudelski@op.pl](jkudelski@op.pl)  \n4 Department of Biochemical Diagnostics, Medical University of Bialystok, Waszyngtona 15A St., 15-269 Bialystok, Poland  \n* [Correspondence: monika.gudowska-sawczuk@umb.edu.pl](Correspondence: monika.gudowska-sawczuk@umb.edu.pl); Tel.: +48-85-831-8703  \nAbstract  \nBladder cancer (BC) is one of the most common urinary tract malignancies. In recent years, increasing attention has been paid to the role of pyroptosis—an inflammatory form of programmed cell death—in cancer development. Gasdermin B (GSDM B), a member of the gasdermin protein family, is involved in the regulation of inflammatory processes and the immune response, and its expression may be associated with cancer development and progression. The aim of the study was to assess GSDM B concentrations in theserum of patients with bladder cancer and to determine its potential diagnostic value in comparison with the tumor markers carcinoembryonic antigen (CEA) and carbohydrate antigen 19-9 (CA19-9) . This study included patients with bladder cancer hospitalized atthe Department of Urology, Medical University of Białystok, and a healthy control group. GSDM B concentrations were determined by Enzyme-Linked Immunosorbent Assay (ELISA), while CEA and CA19-9 concentrations were determined by chemiluminescent microparticle immunoassay (CMIA) . Concentrations in the serum of patients with bladder cancer were significantly higher than in the control group. A positive correlation was found between GSDM B and CEA and CA19-9 concentrations, as well as the age of the subjects. Receiver-operating characteristic (ROC) analysis demonstrated moderate but significant diagnostic value of GSDM B in differentiating patients with BC from healthy controls. No significant differences in GSDM B concentrations were observed between low-and high-grade tumors. These findings suggest that GSDM B may serve as a potential diagnostic marker for bladder cancer, particularly when used as part of amultimarker panel.  \nKeywords: gasdermin B; GSDM B; pyroptosis; bladder cancer; diagnosis; marker  \n1. Introduction  \nUrological cancers constitute a significant global health burden, with bladder cancer (BC) and renal cell carcinoma (RCC) being among the most prevalent malignancies in this category. These cancers originate in different sections of the urinary tract and exhibit diverse histological characteristics and molecular mechanisms [1,2] .  \nBC ranks as the 10th most common cancer worldwide, with approximately 550,000 new cases diagnosed annually [3] . Histologically, the predominant subtype is urothelial carcinoma, accounting for over 90% of cases. Squamous cell carcinoma (SCC), adenocarcinoma (AC), and small cell carcinoma are less common. In terms of the gender distribution, BC occurs approximately four times more frequently in men than women [4] .  \nUrological cancers are influenced by multiple risk factors, including lifestyle choices, environmental exposures, genetic predispositions, and infections. Tobacco smoking remains t","cbCaisXI4U4qGThC","https://ap.wps.com/l/cbCaisXI4U4qGThC","pdf",821335,11,"English","# Abstract\n# Introduction\n## Urological cancer burden and risk factors\n## Clinical presentation and diagnostic methods\n## Gasdermin B and pyroptosis background","[{\"question\":\"What was the purpose of measuring GSDM B in this study?\",\"answer\":\"The study aimed to assess serum GSDM B concentrations in bladder cancer patients and determine their potential diagnostic value compared with CEA and CA19-9.\"},{\"question\":\"How were GSDM B, CEA, and CA19-9 measured?\",\"answer\":\"GSDM B was measured by ELISA, while CEA and CA19-9 were measured by chemiluminescent microparticle immunoassay (CMIA).\"},{\"question\":\"Does GSDM B performance depend on tumor grade in bladder cancer?\",\"answer\":\"No significant differences in GSDM B concentrations were observed between low- and high-grade tumors.\"}]","The Role of Gasdermin B-Mediated Pyroptosis in Bladder Cancer Diagnosis | PDF",1790150205,28,[148,152,156,160],{"page_no":22,"url":149,"width":150,"height":151},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/ef0fd6c8f394d694bf52abe74662f834.webp",983,1390,{"page_no":26,"url":153,"width":154,"height":155},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/319ac0df8fe018d33f6bd84b26825ec3.webp",982,1388,{"page_no":30,"url":157,"width":158,"height":159},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/cfe82300e8c58ef8ae11220623bc2db1.webp",981,1387,{"page_no":33,"url":161,"width":162,"height":163},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c1b72865b495d32791d34881976e1483.webp",980,1385]